CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
atorvastatin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00159835
NCT00159835Phase 4Completed
CompareCT.gov

Atorvastatin Compared With Simvastatin In The Prevention of CHD Morbidity And Mortality In Patients With CHD

Pfizer·interventional·Posted Sep 12, 2005·Updated Apr 22, 2015

In Brief

A Phase 4 clinical trial evaluating atorvastatin and simvastatin for Cardiovascular Diseases. Completed, across 194 sites in 6 countries.

Detailed Summary

To investigate whether a long-term strategy to lower LDL cholesterol with atorvastatin as much as possible will improve prognosis in CHD patients compared with a strategy reflecting current best clinical practice with simvastatin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases
Countries, Denmark, Finland, Iceland, Netherlands, Norway, Sweden
Collaborators--

Timeline

Phase 4CompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 12, 2005
Enrollment StartFeb 1, 1999
Study CompletionMar 1, 2005
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

atorvastatindrug

simvastatindrug